Business
Bench International Announces Appointment of Jim Lang to the Board of Directors of Halozyme Therapeutics
Bench International today announced the appointment of Jim Lang to the Board of Directors of Halozyme Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on advancing innovative drug delivery technologies that improve how medicines are delivered to patients worldwide.
About this update from Biovie Inc.
[{"type":"text","content":"Appointment Strengthens Halozyme's Board as the Company Advances Its Global Drug Delivery Platform","length":102,"tagName":"p"},{"type":"text","content":"SAN DIEGO, Dec. 17, 2025 /PRNewswire/ -- Bench International today announced the appointment of Jim Lang to the Board of Directors of Halozyme Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on advancing innovative drug delivery technologies that improve how medicines are delivered to patients worldwide.","length":335,"tagName":"p"},{"type":"image","alt":"Bench International Logo (PRNewsfoto/Bench International)","displaySize":"","headline":null,"caption":"Bench International Logo (PRNewsfoto/Bench International)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/e802f161434404c572aa8988e01e2734"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RLU1ZMzDdALj39iHngPszg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/e802f161434404c572aa8988e01e2734","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2686747/Bench_updated_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Mr. Lang brings extensive experience scaling life sciences organizations and providing governance oversight for public companies operating in complex, highly regulated environments. He currently serves on the public boards of OptimizeRx Corp. and BioVie Inc. His background includes supporting enterprise growth, guiding strategic partnerships, and advising leadership teams through periods of transformation and expansion across multiple stages of company development. This expertise aligns closely with Halozyme's objectives as it advances its drug delivery portfolio and global collaborations with leading pharmaceutical partners.","length":637,"tagName":"p"},{"type":"text","content":""Jim brings the rare combination of public-company board experience, strategic scale expertise, and deep understanding of complex life sciences ecosystems," said Denise (DeeDee) DeMan, Founder, Chairman, and Chief Executive Officer of Bench International. "We were honored to partner with Halozyme on this important board appointment and to support the company's continued evolution as a leader in drug delivery...